Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Immunohistochemical analysis of molecular drivers in melanoma identifies p16 as an independent prognostic biomarker

7 Mar 2014

Abstract excerpt

AIMS: To perform immunohistochemical (IHC) analysis of molecular drivers related to the development and maintenance of melanoma and to assess their value as diagnostic and prognostic melanoma biomarkers in routine clinical practice. METHODS: Tissue microarrays constructed from a cohort of primary melanomas (n=355), benign naevi (n=37) and melanoma metastases (n=14) were evaluated for IHC expression of c-KIT,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cutaneous Melanoma Detection and Management
Share to melanin and skin pigmentation
Share to Melanoma and MAPK Pathways

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 24607493
DOI: 10.1136/jclinpath-2013-202127

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Immunohistochemical analysis of molecular drivers in melanoma identifies p16 as an independent prognostic biomarkerPMID 24607493Read ↗

Comprehensive DNA methylation study identifies novel progression-related and prognostic markers for cutaneous melanomaSemantic proximity Read ↗

The Melanoma Pathology Report: What to Expect and How to Interpret ItSemantic proximity Read ↗

Prognostic and predictive biomarkers in melanoma: an updateSemantic proximity Read ↗

Treatment implications of the emerging molecular classification system for melanoma.Semantic proximity Read ↗

Analysis of Genetic Alterations in Cutaneous Malignant Melanomas Unveils Unique Loco-Regional Variations and Novel Predictors of Metastatic Potential.Semantic proximity Read ↗

BRAF alterations are associated with complex mutational profiles in malignant melanoma.Semantic proximity Read ↗

Molecular profiling reveals low- and high-grade forms of primary melanoma.Semantic proximity Read ↗

BRAF-V600E expression in primary nodular melanoma is associated with aggressive tumour features and reduced survival.Semantic proximity Read ↗

Disease progression and patient survival are significantly influenced by BRAF protein expression in primary melanoma.Semantic proximity Read ↗

p53-related pathways and the molecular pathogenesis of melanomaSemantic proximity Read ↗

Prognostic and predictive values of oncogenic BRAF, NRAS, c-KIT and MITF in cutaneous and mucous melanoma.Semantic proximity Read ↗

Association of BRAF Mutation Status with Histopathological Characteristics and Survival Outcomes in Stage II-III Malignant Melanoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.